MAPT and Alzheimer disease: In turn, Li and colleagues studied the effects of intraperitoneal injection of 200 mg kg−1 d−1 of metformin for 18 weeks in db/db mice, which have multiple AD-like brain changes such as alterations in cognitive functions, increased phospho-tau and Aβ, as well as decreased synaptic proteins.